The U.S. Food and Drug Administration is requiring imaging dyes used in MRIs and other procedures to carry new warnings about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF) if the drug is administered to kidney patients. – (AHN)
Read the original post by NY Daily News